CSIMarket
 
Fibrogen Inc   (FGEN)
Other Ticker:  
 
 

Fibrogen Inc Income Statement Quarterly

FGEN


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 40.13 44.32 36.16 15.74
Revenue From Contract With Customer Excluding Assessed Tax - - - -
License Fees And Milestones Revenue - - - -
Collaboration Services And Other Revenue - - - -
Development And Other Revenue - - - -
Total Revenue 40.13 44.32 36.16 34.37 15.74
Cost of Revenue 4.24 5.71 3.49 4.93 4.31
Gross Profit 35.89 38.61 32.67 29.44 11.43
Selling, Administration, Marketing 25.57 31.18 34.28 33.96 29.90
Depriciation & Amortization - - - - -
Research and Development Expense 61.19 95.48 74.49 61.63 75.18
Restructuring Charges 12.61 - - - -
Other operatinig exp. /-income 0.00 0.00 - - -
Unusual Expense /-Income - - - - -
Total operating costs including COS 103.62 132.37 112.25 100.52 109.39
Operating income/-loss -63.48 -88.05 -76.09 -66.15 -93.66
Other Deductions / - Income
Interest expense 5.02 3.07 2.37 1.12 0.08
Interest income - - - - -
Net interest expense/-income 0.73 0.42 1.34 -1.04 1.71
Loss (Income) from Equity Method Investments - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income 0.00 0.00 0.00 1.23 -3.43
Total costs & expenses 104.34 132.78 113.59 100.71 107.68
Income /-loss before income taxes -64.21 -88.47 -77.43 -66.35 -91.94
Income taxes expenses/-benefit -0.08 -0.24 -0.07 -0.11 -0.11
Income after income taxes -63.62 -87.68 -76.71 -66.18 -91.65
Net income/-loss of other equity 0.51 0.55 0.65 0.06 0.18
Income/-loss from cont. Ops. -63.62 -87.68 -76.71 -66.18 -91.65
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -63.62 -87.68 -76.71 -66.18 -91.65
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -63.62 -87.68 -76.71 -66.18 -91.65
EBIT -63.48 -88.05 -76.09 -67.38 -90.23
EBITD -60.85 -85.57 -73.55 -64.87 -87.69
EBITDA -60.85 -85.57 -73.55 -64.87 -87.69


Per Share (GAAP Quarterly, in $) (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Basic EPS (excl. extra items) -0.65 -0.90 -0.81 -0.70 -0.98
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.65 -0.90 -0.81 -0.70 -0.98
Basic shares outstanding (Mill. of Units) 98.25 97.73 94.69 94.04 93.77
   EPS other shares - - - - -
Diluted Net EPS -0.65 -0.90 -0.81 -0.70 -0.98
Diluted average shares (Mill. of Units) 98.25 97.73 94.69 93.52 93.77
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com